Clinical implications of plasma Epstein-Barr virus DNA in early-stage extranodal nasal-type NK/T-cell lymphoma patients receiving primary radiotherapy
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical implications of plasma Epstein-Barr virus DNA in early-stage extranodal nasal-type NK/T-cell lymphoma patients receiving primary radiotherapy
Authors
Keywords
-
Journal
BLOOD
Volume 120, Issue 10, Pages 2003-2010
Publisher
American Society of Hematology
Online
2012-07-24
DOI
10.1182/blood-2012-06-435024
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pretreatment EBV-DNA Copy Number Is Predictive of Response and Toxicities to SMILE Chemotherapy for Extranodal NK/T-cell Lymphoma, Nasal Type
- (2012) Y. Ito et al. CLINICAL CANCER RESEARCH
- Prospective measurement of Epstein-Barr virus-DNA in plasma and peripheral blood mononuclear cells of extranodal NK/T-cell lymphoma, nasal type
- (2011) R. Suzuki et al. BLOOD
- Bortezomib induction of C/EBP mediates Epstein-Barr virus lytic activation in Burkitt lymphoma
- (2011) C. M. Shirley et al. BLOOD
- Failure patterns and clinical implications in early stage nasal natural killer/T-cell lymphoma treated with primary radiotherapy
- (2011) Ye-Xiong Li et al. CANCER
- The Viral Load of Epstein-Barr Virus (EBV) DNA in Peripheral Blood Predicts for Biological and Clinical Characteristics in Hodgkin Lymphoma
- (2011) S. Hohaus et al. CLINICAL CANCER RESEARCH
- Radiotherapy Alone With Curative Intent in Patients With Stage I Extranodal Nasal-Type NK/T-Cell Lymphoma
- (2011) Ye-Xiong Li et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Phase II Study of SMILE Chemotherapy for Newly Diagnosed Stage IV, Relapsed, or Refractory Extranodal Natural Killer (NK)/T-Cell Lymphoma, Nasal Type: The NK-Cell Tumor Study Group Study
- (2011) Motoko Yamaguchi et al. JOURNAL OF CLINICAL ONCOLOGY
- Immunophenotypic characteristics and clinical relevance of CD56+ and CD56− extranodal nasal-type natural killer/T-cell lymphoma
- (2011) Ye-xiong Li et al. LEUKEMIA & LYMPHOMA
- Unfavorable prognosis of elderly patients with early-stage extranodal nasal-type NK/T-cell lymphoma
- (2010) Z. Y. Wang et al. ANNALS OF ONCOLOGY
- A novel latent membrane 2 transcript expressed in Epstein-Barr virus-positive NK- and T-cell lymphoproliferative disease encodes a target for cellular immunotherapy
- (2010) C. P. Fox et al. BLOOD
- Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study
- (2010) A. Jaccard et al. BLOOD
- Interlaboratory Comparison of Epstein-Barr Virus Viral Load Assays
- (2009) J. K. Preiksaitis et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Primary radiotherapy showed favorable outcome in treating extranodal nasal-type NK/T-cell lymphoma in children and adolescents
- (2009) Z.-Y. Wang et al. BLOOD
- Variable Clinical Presentations of Nasal and Waldeyer Ring Natural Killer/T-Cell Lymphoma
- (2009) Y.-X. Li et al. CLINICAL CANCER RESEARCH
- Phase I/II Study of Concurrent Chemoradiotherapy for Localized Nasal Natural Killer/T-Cell Lymphoma: Japan Clinical Oncology Group Study JCOG0211
- (2009) Motoko Yamaguchi et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Trial of Concurrent Radiation and Weekly Cisplatin Followed by VIPD Chemotherapy in Newly Diagnosed, Stage IE to IIE, Nasal, Extranodal NK/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma Study
- (2009) Seok Jin Kim et al. JOURNAL OF CLINICAL ONCOLOGY
- Whole blood Epstein-Barr virus DNA load as a diagnostic and prognostic surrogate: extranodal natural killer/T-cell lymphoma
- (2009) Hyo Song Kim et al. LEUKEMIA & LYMPHOMA
- Treatment outcome of radiotherapy alone versus radiochemotherapy in early stage nasal natural killer/T-cell lymphoma
- (2009) Hui-Hui Ma et al. MEDICAL ONCOLOGY
- Phase I study of proteasome inhibitor bortezomib plus CHOP in patients with advanced, aggressive T-cell or NK/T-cell lymphoma
- (2008) J. Lee et al. ANNALS OF ONCOLOGY
- Clinical heterogeneity of extranodal NK/T-cell lymphoma, nasal type: a national survey of the Korean Cancer Study Group
- (2008) T. M. Kim et al. ANNALS OF ONCOLOGY
- Clinical features and treatment outcome of nasal-type NK/T-cell lymphoma of Waldeyer ring
- (2008) Y.-X. Li et al. BLOOD
- Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project
- (2008) W.-y. Au et al. BLOOD
- Expression levels of apoptosis-related proteins and Ki-67 in nasal NK / T-cell lymphoma
- (2008) Hajime Yasuda et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Early or Up-Front Radiotherapy Improved Survival of Localized Extranodal NK/T-Cell Lymphoma, Nasal-Type in the Upper Aerodigestive Tract
- (2007) Mei-juan Huang et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started